|
US2021122828A1
|
|
Humanized antibodies to tnf-like ligand 1a (tl1a) and uses thereof
|
|
WO2021081365A1
|
|
Humanized antibodies to tnf-like ligand 1a (tl1a) and uses thereof
|
|
WO2020232125A1
|
|
Tl1a patient selection methods, systems, and devices
|
|
TW202043234A
|
|
Gpr35 modulators
|
|
WO2020117795A1
|
|
Assessment and monitoring of mucosal healing in children and adults with crohn's disease
|
|
KR20210005169A
|
|
Optimized anti-TL1A antibody
|
|
EP3695229A1
|
|
Methods for monitoring vedolizumab treatment
|
|
US2020264171A1
|
|
Methods for assessing mucosal healing in crohn's disease patients
|
|
US2020109530A1
|
|
Gate for controlling oncoming traffic on a roadway
|
|
EP1623211A2
|
|
Systems and methods for monitoring chemical and biolgical activities using differential measurements
|
